| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/08/2012 | EP2415466A1 Orally disintegrating coated tablet |
| 02/08/2012 | EP2415465A1 Stabiliser-free pharmaceutical compositions of tetrahydrolipstatin |
| 02/08/2012 | EP2415464A1 Method for producing liposome composition |
| 02/08/2012 | EP2415463A1 Particulate medicinal composition |
| 02/08/2012 | EP2415462A1 Improved pharmaceutical compositions for poorly soluble drugs |
| 02/08/2012 | EP2415461A1 Stabilization of interleukin 6 in serum based solutions |
| 02/08/2012 | EP2414389A1 Tumor targeting peptides, therapeutic and diagnostic compositions comprising the peptides |
| 02/08/2012 | EP2413975A1 Lipopeptide inhibitors of hiv-1 |
| 02/08/2012 | EP2413974A1 Conjugated antimicrobial agents |
| 02/08/2012 | EP2413973A1 Polymeric conjugates of paclitaxel and docetaxel with ph-controlled releasing of the cancerostatic agent |
| 02/08/2012 | EP2413972A1 Bonding products of aminated polysaccharides |
| 02/08/2012 | EP2413971A1 Plant fiber product and method for its manufacture |
| 02/08/2012 | EP2413936A1 Co-crystal of etravirine and nicotinamide |
| 02/08/2012 | EP2413917A2 Drug delivery system and methods of use |
| 02/08/2012 | EP2413916A2 Lyophilization cakes of proteasome inhibitors |
| 02/08/2012 | EP2413914A2 An artificial micro-gland |
| 02/08/2012 | EP2413907A2 Method for producing preparations of substances poorly soluble in water |
| 02/08/2012 | EP2413898A1 Modified-release pharmaceutical drug composition |
| 02/08/2012 | EP2413895A1 Novel thickening polymer in the form of a powder |
| 02/08/2012 | EP2413719A1 Method for preparing functionalized lipid capsules |
| 02/08/2012 | EP2413694A1 A peg-albumin composition having at least one protected thiol region as a platform for medications |
| 02/08/2012 | EP1933809B1 Compositions for nasal delivery |
| 02/08/2012 | EP1567117B1 Prevention and treatment of microbe-mediated epithelial disorders |
| 02/08/2012 | EP1267924B1 Immunotherapeutic methods and compositions |
| 02/08/2012 | CN1620413B 还原型辅酶Q<sub>10</sub>的稳定方法和组合物 Coenzyme Q <sub> 10 </ sub> stabilization methods and compositions |
| 02/08/2012 | CN102348723A Peptide therapeutic conjugates and uses thereof |
| 02/08/2012 | CN102348469A Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/08/2012 | CN102348465A Ameliorating agent for chronic obstructive pulmonary disease |
| 02/08/2012 | CN102348464A Injectable biomaterials |
| 02/08/2012 | CN102348458A Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 02/08/2012 | CN102348455A Active coating of pharmaceutical dosage forms |
| 02/08/2012 | CN102344686A Method for preparing fibroin nanoparticles taking polyvinyl alcohol as stabilizer |
| 02/08/2012 | CN102344633A Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 02/08/2012 | CN102344409A Amlodipine crystal, medicine composition of amlodipine crystal and benazepril as well as method for preparing medicine composition |
| 02/08/2012 | CN102344371A Temperature-sensing amphiphilic polyether dendrons and their preparation method and use |
| 02/08/2012 | CN102344151A Prussian blue nano-scale hollow olivary microballoons |
| 02/08/2012 | CN102343101A Preparation method and application of functionalized kaolin nanotube-antisense oligonucleotide medicine carrier |
| 02/08/2012 | CN102343100A Method for quickly preparing rutin inclusion compound |
| 02/08/2012 | CN102343099A Preparation method and application of folacin mediated tumor targeting adriamycin prodrugs |
| 02/08/2012 | CN102343098A Functionalized magnetic nanoparticles and methods of use thereof |
| 02/08/2012 | CN102343097A Method for preparing cefradine/montmorillonite intercalation composite material by montmorillonite sodium modification |
| 02/08/2012 | CN102343096A Andrographolide cyclodextrin inclusion compound, preparation method and application thereof |
| 02/08/2012 | CN102343095A Xylitol medicinal intermediate |
| 02/08/2012 | CN102343094A Compositions and methods of delivery of pharmacological agents |
| 02/08/2012 | CN102343093A Seaweed polysaccharide medicinal plant film coating and preparation method thereof |
| 02/08/2012 | CN102343092A Drug carrier and drug carrier kit for inhibiting fibrosis |
| 02/08/2012 | CN102343054A Film coating used for stomach invigorating and digestion promoting tablets, and preparation method thereof |
| 02/08/2012 | CN102342967A Thin film coated tablets containing vitamin, ginseng and zinc sulfate and preparation method thereof |
| 02/08/2012 | CN102342964A Andrographolidume sustained-release preparation as well as preparation method and use of same |
| 02/08/2012 | CN102342950A Transdermal solution for treating parasitic diseases of livestock and poultry and preparation method thereof |
| 02/08/2012 | CN102342937A Amlodipine and candesartan pharmaceutical composition and preparation method thereof |
| 02/08/2012 | CN102342931A Injectable parenteral medicinal preparation of temozolomide and preparation method thereof |
| 02/08/2012 | CN102342930A Fenticonazole nitrate medicinal composition |
| 02/08/2012 | CN102342925A Compositions for treating infection in cattle and swine |
| 02/08/2012 | CN102342924A Medicine composition containing agomelatine |
| 02/08/2012 | CN102342920A Pharmaceutical composition containing alarelin acetate and preparation method thereof |
| 02/08/2012 | CN102342919A Preparation method for 5-fluorouracil/PLGA (Polylactic-co-Glycolic Acid) medicine carrying microspheres |
| 02/08/2012 | CN102342918A Colon-targeting coating system, colon-targeting oral preparation and preparation method of colon-targeting oral preparation |
| 02/08/2012 | CN102342917A Slow release oral solid preparation with Nilvadipine as active component |
| 02/08/2012 | CN102342916A Lansoprazole enteric-coated capsule prescription and preparation method thereof |
| 02/08/2012 | CN102342915A Method for preparing antihypertensive peptide microsphere with intestine site-specific delivery drugs release effect |
| 02/08/2012 | CN102342912A Candesartan cilexetil nanoemulsion and preparation method thereof |
| 02/08/2012 | CN102342910A Levofloxacin hydrochloride injection pharmaceutical composition and preparation method thereof |
| 02/08/2012 | CN102342907A Dronedarone solid dispersoid and preparation method thereof |
| 02/08/2012 | CN101850123B 核壳型荧光标记磁性药物无机纳米杂化材料及制备方法 Magnetic core-shell fluorescent labeled drug Inorganic Hybrid Materials and preparation methods |
| 02/08/2012 | CN101716349B 一种用于栓塞治疗和止痛的药物组合物及其制备方法 An embolization and analgesic pharmaceutical composition and its preparation method |
| 02/08/2012 | CN101711871B 银纳米链网状材料及制备方法和在制备治疗肿瘤药物中的应用 Nano silver chain mesh material and preparation method and application in the manufacture of a medicament for the treatment of cancer |
| 02/08/2012 | CN101670092B 一种注射用促肝细胞生长素冻干粉针剂的制备方法 An injectable preparation pHGF freeze-dried powder |
| 02/08/2012 | CN101633711B 一种含金刚烷基的温敏性水凝胶及其制备方法与应用 Temperature-sensitive hydrogels and its preparation method and application of containing adamantyl |
| 02/08/2012 | CN101613365B 基于季戊四醇的复合脂质及其制备方法 Complex lipid and its preparation method based on pentaerythritol |
| 02/08/2012 | CN101601653B 泼尼卡酯脂质体乳膏 Nika ester liposomes cream splash |
| 02/08/2012 | CN101590020B 一种对氨基水杨酸钠结肠定位给药系统 A kind of amino Acid Sodium Colon drug delivery system |
| 02/08/2012 | CN101559036B 一种阴道用避孕凝胶组合物及其制备方法和应用 One kind of vaginal contraceptive gel composition and preparation method and application |
| 02/08/2012 | CN101516348B 含有布洛芬和氨甲环酸的固形制剂 Containing ibuprofen and tranexamic acid solid preparation |
| 02/08/2012 | CN101467959B 持续释放组合物及其制备方法 Sustained release composition and preparation method |
| 02/08/2012 | CN101440113B 秋水仙碱衍生物-胆汁酸偶合物及其医药用途 Colchicine Derivatives - bile acid conjugate and medical use |
| 02/08/2012 | CN101415395B 酪蛋白纳米粒子 Casein nanoparticle |
| 02/08/2012 | CN101189003B Hdac抑制剂的药物制剂 Inhibitor pharmaceutical preparations Hdac |
| 02/08/2012 | CN101011398B 一种盐酸阿莫地喹包衣微粒及其制备方法 One kind of amodiaquine hydrochloride coated microparticles and preparation method |
| 02/07/2012 | US8110657 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/07/2012 | US8110600 Formulation and delivery method to enhance antioxidant potency of vitamin E |
| 02/07/2012 | US8110565 Of the ACE inhibitor ramipril; controlling the melting point by mixing with the free acid with the ramipril ethyl or methyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 02/07/2012 | US8110564 Bile acid or bile salt fatty acid conjugates |
| 02/07/2012 | US8110554 Peptides whose uptake by cells is controllable |
| 02/07/2012 | US8110541 Antigen delivery vectors and constructs |
| 02/07/2012 | US8110540 Antigen delivery vectors and constructs |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110225 Treatment using dantrolene |
| 02/07/2012 | US8110224 Matrix containing biodegradable polymer, water soluble polymer and drugs; mixture containing water insoluble surfactant such as lecithin or phosphatide |
| 02/07/2012 | US8110221 Encapsulation of oxygen sensitive agents with soy protein or casein and a modified starch |
| 02/07/2012 | US8110212 Bioactive thermogelling polymer systems and methods of their use |
| 02/07/2012 | US8110209 Intracutaneous injection |
| 02/07/2012 | US8110196 Methods and compositions for polytopic vaccination |
| 02/07/2012 | US8110179 A water-soluble, cyclodextrin-containing linear polymer having bioactive moieties to attached a drug(s) or modified drug to the polymer covalently; cleavage under biological conditions to release the bioactive moieties; sustained release; side effect reduction; stability; nontoxic; drug polymer conjugate |
| 02/07/2012 | US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/07/2012 | CA2624175C Cgrp peptide antagonists and conjugates |
| 02/07/2012 | CA2522295C Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom |
| 02/07/2012 | CA2521612C Non-ionic surfactant comprising polyoxyalkylene glycol hydroxy fatty acid derivatives for solubilizing poorly soluble molecules |
| 02/07/2012 | CA2519351C Controlled release system |
| 02/07/2012 | CA2516816C Transmucosal drug delivery system |